114 related articles for article (PubMed ID: 26753818)
1. Using PG-Liposome-Based System to Enhance Puerarin Liver-Targeted Therapy for Alcohol-Induced Liver Disease.
Zhao YZ; Zhang L; Gupta PK; Tian FR; Mao KL; Qiu KY; Yang W; Lv CZ; Lu CT
AAPS PharmSciTech; 2016 Dec; 17(6):1376-1382. PubMed ID: 26753818
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and tissue distribution profile of icariin propylene glycol-liposome intraperitoneal injection in mice.
Yang W; Yu XC; Chen XY; Zhang L; Lu CT; Zhao YZ
J Pharm Pharmacol; 2012 Feb; 64(2):190-8. PubMed ID: 22221094
[TBL] [Abstract][Full Text] [Related]
3. [Preparation of puerarin liposome and its oral absorption in rat].
Gu YZ; Zhou W; Zhai GX
Zhong Yao Cai; 2007 Aug; 30(8):970-3. PubMed ID: 18074848
[TBL] [Abstract][Full Text] [Related]
4. [Preparation and lacrimal pharmacokinetics of eye drops of puerarin liposomes in rabbit tears].
Deng Y; Xu J; Li X
Zhongguo Zhong Yao Za Zhi; 2010 Feb; 35(3):301-4. PubMed ID: 20422993
[TBL] [Abstract][Full Text] [Related]
5. Preparation, characterization, and pharmacokinetic evaluation of puerarin submicron emulsion.
Yue PF; Yuan HL; Yang M; You RH; Cong LB; Zhu J; Wang Q; Zhu WF; Xiao XH
PDA J Pharm Sci Technol; 2008; 62(1):32-45. PubMed ID: 18402366
[TBL] [Abstract][Full Text] [Related]
6. Formulation optimization of self-emulsifying preparations of puerarin through self-emulsifying performances evaluation in vitro and pharmacokinetic studies in vivo.
Quan DQ; Xu GX
Yao Xue Xue Bao; 2007 Aug; 42(8):886-91. PubMed ID: 17944241
[TBL] [Abstract][Full Text] [Related]
7. Epirubicin loaded with propylene glycol liposomes significantly overcomes multidrug resistance in breast cancer.
Zhao YZ; Dai DD; Lu CT; Chen LJ; Lin M; Shen XT; Li XK; Zhang M; Jiang X; Jin RR; Li X; Lv HF; Cai L; Huang PT
Cancer Lett; 2013 Mar; 330(1):74-83. PubMed ID: 23186833
[TBL] [Abstract][Full Text] [Related]
8. Formulation development and pharmacokinetics of puerarin self-emulsifying drug delivery systems.
Dong-Qin Q; Gui-Xia X; Xiang-Gen W
PDA J Pharm Sci Technol; 2007; 61(1):37-43. PubMed ID: 17390702
[TBL] [Abstract][Full Text] [Related]
9. Propylene glycol-embodying deformable liposomes as a novel drug delivery carrier for vaginal fibrauretine delivery applications.
Li WZ; Hao XL; Zhao N; Han WX; Zhai XF; Zhao Q; Wang YE; Zhou YQ; Cheng YC; Yue YH; Fu LN; Zhou JL; Wu HY; Dong CJ
J Control Release; 2016 Mar; 226():107-14. PubMed ID: 26883754
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol anchored arabinogalactan for asialoglycoprotein receptor targeting: synthesis, characterization, and proof of concept of hepatospecific delivery.
Pathak PO; Nagarsenker MS; Barhate CR; Padhye SG; Dhawan VV; Bhattacharyya D; Viswanathan CL; Steiniger F; Fahr A
Carbohydr Res; 2015 May; 408():33-43. PubMed ID: 25841057
[TBL] [Abstract][Full Text] [Related]
11. [Preparation and characterization of chitosan coated puerarin liposomes].
Wang HG; Zhai GX; Lü QZ; Ling PX
Zhong Yao Cai; 2007 Jan; 30(1):89-92. PubMed ID: 17539312
[TBL] [Abstract][Full Text] [Related]
12. Enhanced in vitro and in vivo skin deposition of apigenin delivered using ethosomes.
Shen LN; Zhang YT; Wang Q; Xu L; Feng NP
Int J Pharm; 2014 Jan; 460(1-2):280-8. PubMed ID: 24269286
[TBL] [Abstract][Full Text] [Related]
13. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S
Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160
[TBL] [Abstract][Full Text] [Related]
14. Formulation and pharmacokinetics evaluation of puerarin nanocrystals for intravenous delivery.
Wang Y; Ma Y; Ma Y; Du Y; Liu Z; Zhang D; Zhang Q
J Nanosci Nanotechnol; 2012 Aug; 12(8):6176-84. PubMed ID: 22962724
[TBL] [Abstract][Full Text] [Related]
15. Effects of particle size on the pharmacokinetics of puerarin nanocrystals and microcrystals after oral administration to rat.
Tu L; Yi Y; Wu W; Hu F; Hu K; Feng J
Int J Pharm; 2013 Dec; 458(1):135-40. PubMed ID: 24120729
[TBL] [Abstract][Full Text] [Related]
16. Polyamidomine dendrimers: an excellent drug carrier for improving the solubility and bioavailability of puerarin.
Gu L; Wu Zh; Qi X; He H; Ma X; Chou X; Wen X; Zhang M; Jiao F
Pharm Dev Technol; 2013; 18(5):1051-7. PubMed ID: 22303809
[TBL] [Abstract][Full Text] [Related]
17. A novel glycyrrhetinic acid-modified oxaliplatin liposome for liver-targeting and in vitro/vivo evaluation.
Chen J; Jiang H; Wu Y; Li Y; Gao Y
Drug Des Devel Ther; 2015; 9():2265-75. PubMed ID: 25945038
[TBL] [Abstract][Full Text] [Related]
18. c(RGDfK) anchored surface manipulated liposome for tumor-targeted tyrosine kinase inhibitor (TKI) delivery to potentiate liver anticancer activity.
Deepak P; Kumar P; Arya DK; Pandey P; Kumar S; Parida BP; Narayan G; Singh S; Rajinikanth PS
Int J Pharm; 2023 Jul; 642():123160. PubMed ID: 37379892
[TBL] [Abstract][Full Text] [Related]
19. Folate receptor-targeted liposomes loaded with a diacid metabolite of norcantharidin enhance antitumor potency for H22 hepatocellular carcinoma both in vitro and in vivo.
Liu MC; Liu L; Wang XR; Shuai WP; Hu Y; Han M; Gao JQ
Int J Nanomedicine; 2016; 11():1395-412. PubMed ID: 27110110
[TBL] [Abstract][Full Text] [Related]
20. [Preparation of puerarin solid self-microemulsion].
Yu AH; Zhai GX; Cui J; Liu H
Zhong Yao Cai; 2006 Aug; 29(8):834-8. PubMed ID: 17076244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
